Login
Home / BVAXF : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BioVaxys Technology Corp.

$0.08 -$0.09 (-50.95%)
OTC · 14 Sep 2026 18:18 UTC
Previous Close
$0.1
Day Range
$0.07$0.08
Year Range
$0.02$0.23
Market Cap
2.45M
AVG Volume
35.21K
Trailing/Forward PE
-0.91/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (CAD)
-4M-2M02M23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Operating Income (CAD)
-6M-4M-2M023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
EBITDA (CAD)
-6M-4M-2M023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Cash Flows (CAD)
-1.5M-1M-500K0500K23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
EPS (CAD)
-0.3-0.2-0.1-00.123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Expenses (CAD)
0500K1M1.5MR&DSG&A23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Cash & Debt (CAD)
0250K500K750K1MCashShort Term Debt23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Debt ratios
-0.0500.050.10.1523 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Return on Capital
-200%0%200%400%600%23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Shares Outstanding
010M20M30M23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Book Value Per Share (CAD)
-0.3-0.2-0.1-00.123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Total Assets (CAD)
01M2M3M23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Free Cash Flow Yield
-300%-200%-100%0%med -45.12%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
123456med 2.09Aug 21Nov 21Mar 22Jun 22Sep 22Jan 23Oct 23
BioVaxys Technology Corp.
BVAXF
Stockpicker

Video analysis: BVAXF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BVAXF

BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

newsfilecorp.com · 8 Sep 2026

BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2026) - BioVaxys Technology Corp. (OTC Pink: BVAXF) (CSE: BIOV) (FSE: 5LB), ("BioVaxys" or the "Company") a clinical-stage biopharmaceutical company focused on the development of durable, single-dose, vaccines for safe, scalable, and long-lasting immune protection in oncology, infectious disease, and immune dysfunctions, is pleased to announce its participation at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place September 9-10, 2026, in New York City. James Passin, Chief Executive Officer, will be attending the conference, delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.